GATA3 and neoplasm: This confirms that FOXA1 and GATA3 expression is commonly and recurrently elevated in the majority of early neoplasias (40/59 cases strong and 15/59 cases intermediate staining for FOXA1; 31/57 cases strong and 21/57 cases intermediate staining for GATA3).